ArticleNeuro-oncology advances

Response to entrectinib in a malignant glioneuronal tumor with ARHGEF2-NTRK fusion.

Kazuhiko Kurozumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.